If you suffer from multi-joint pain (polyarthralgia): fly to Medellín, Colombia and treat it with stem cells

When several joints hurt at once, treating just one is like putting out a fire with a glass of water. multi-joint pain (polyarthralgia) is one of the most common reasons patients from the US, Europe, the Middle East and Latin America fly to Medellín every month looking for expanded mesenchymal stem cell therapy. They don't come chasing a discount — they come because at home their options end in anti-inflammatories, cortisone or surgery.

1. What is multi-joint pain (polyarthralgia) and why does it become chronic?

Multi-joint pain (polyarthralgia) is rarely an isolated mechanical issue. In most patients we evaluate it combines low-grade inflammation, progressive cartilage or tendon degeneration, and a dysregulated local immune response. That's why anti-inflammatories and cortisone injections give temporary relief but don't modify the disease — and often accelerate long-term joint damage.

The most common causes we see in clinic:

• Osteoarthritis in multiple joints (knees, hands, hips).
• Systemic low-grade inflammation (metabolic syndrome).
• Fibromyalgia and diffuse musculoskeletal pain.
• Persistent post-COVID with arthralgia.
• Mild autoimmunity (early non-destructive arthritis).

2. How stem cells act on multi-joint pain (polyarthralgia)

We use allogeneic mesenchymal stem cells (MSCs) from umbilical cord, processed and expanded in a GMP-grade lab. In the joints these cells work through three mechanisms: immune modulation (they lower the chronic inflammatory environment), release of trophic factors (VEGF, TGF-β, IGF-1) and stimulation of endogenous repair of cartilage, tendon or disc.

In multi-joint pain we prioritize systemic IV MSCs as the treatment core, complemented with local injections in the most limiting joint, peptides, NAD+ and an aggressive metabolic plan.

3. Are you a candidate with this multi-joint pain (polyarthralgia) presentation?

You likely are if you present with:

• Persistent joints pain for more than 3 months, with or without previous injections.
• Imaging showing mild to moderate degeneration (not end-stage destruction).
• A desire to avoid or delay surgery and commit to rehabilitation.
• Good overall health (no active infection, no active cancer).

It's not a good indication if:

• Active rheumatoid arthritis with ongoing structural damage.
• Vasculitis or uncontrolled systemic autoimmune disease.
• Fever, weight loss or signs of systemic infection.

4. Diagnostic studies we need

Before defining a protocol for your multi-joint pain (polyarthralgia), we request the following studies (or coordinate them in Medellín within 24–48 h):

• Imaging of the 1–2 most symptomatic joints.
• Full inflammatory panel (CRP, ESR, ferritin, rheumatoid factor, ANA).
• Metabolic and hormonal panel (glucose, HbA1c, thyroid, testosterone/DHEA).
• Vitamin D, B12 and nutritional panel.

5. How we apply stem cells for multi-joint pain (polyarthralgia)

IV sessions of 45–90 minutes. Local applications spread over 2–3 days to minimize cumulative inflammatory response.

The complete protocol usually combines:

• Local ultrasound- or fluoroscopy-guided application by Dr. Joaqui.
• Systemic IV MSC dose to modulate whole-body inflammation.
• Regenerative peptides (BPC-157, TB-500, CJC/Ipamorelin depending on case).
• Biomechanical rehab post-application and personalized supplementation.

6. Expected results and timeline

• Weeks 2–6: clear drop in the inflammatory component; resting pain usually improves first.
• Months 2–3: better range of motion and load tolerance.
• Months 3–6: regenerative effect consolidates; a booster dose is evaluated.
• 60–85% of properly selected patients report significant pain reduction at 12 months.

7. Treatment cost for multi-joint pain (polyarthralgia) in Medellín

Typical range for integrated multi-joint pain (polyarthralgia) care: USD 7,500–15,000, depending on whether the plan combines local injection, IV dose, peptides and/or exosomes. Includes consultations, cells with lot certificate, applications, control labs and 6 months of telemedicine follow-up.

In the US, comparable protocols cost between USD 15,000 and 45,000 and rarely include structured follow-up.

8. What the trip to Medellín looks like

1. Initial teleconsult (30–45 min) with Dr. Joaqui.
2. You share recent imaging and labs of your joints.
3. You receive a personalized protocol, schedule and closed budget.
4. We coordinate medical hotel, transfers and translator if needed.
5. Typical stay in Medellín: 7–10 días / days with 2–3 application sessions.
6. You go home with a written rehab protocol and active telemedicine for 6 months.

9. Safety and traceability

Colombia regulates cell therapy through INVIMA and institutional ethics committees. Every cell lot we use for your multi-joint pain (polyarthralgia) includes reports of viability > 90%, MSC phenotype (CD73⁺, CD90⁺, CD105⁺; CD34⁻, CD45⁻), sterility and full donor traceability.

10. Real testimonial from a patient with multi-joint pain (polyarthralgia)

"I felt 70 at 48. After the IV protocol with stem cells, NAD+ and peptides, I got back to playing with my kids without thinking about pain."

11. Frequently asked questions

About Dr. Joaqui

Dr. William Joaqui is one of the leading references in regenerative medicine and stem cell therapy in Latin America. He has developed integrated protocols with MSCs, exosomes, peptides, NAD+ and biomechanical rehab for joint, tendon and spine conditions. He personally attends every international patient from the initial teleconsult.